CLINICAL TRIAL

PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2026-07-10
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

Ottawa Hospital Research Institute

Watch author

Derived topics and classifications

psilocybin Depression Anxiety End-of-Life Distress Receptor Pharmacology Aging Microdosing Wellbeing Emotional Processing Clinical Trial Randomized Controlled Trial Cancer Patients Healthcare Workers Safety Adverse Events Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Optimizing Microdosing and MeditationClinicalTrials.gov · 2025-06-05 Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot StudyClinicalTrials.gov · 2026-06-23